Tag: Motley Fool

  • 3 compelling ASX payment shares to buy

    Payment Technology

    This article is about three ASX payment shares that investors may find compelling.

    Visa and MasterCard are the biggest payment businesses in the world, but they are listed in the US. But on the ASX there are a number of other options that give exposure to the payment sector:

    Pushpay Holdings Ltd (ASX: PPH)

    According to the ASX, Pushpay has a market capitalisation of $2.1 billion.

    Pushpay is a business that facilitates electronic donations, largely to large and medium US churches.

    The company wants to become the market leader with a market share of more than 50%, which will help it achieve its long-term goal of US$1 billion of revenue.

    Social distancing and COVID-19 restrictions are causing Pushpay’s growth to accelerate. Its app includes a livestreaming service, which is popular under these conditions.

    Pushpay is demonstrating its scalability. In the recent FY21 interim result, it reported that its gross profit margin increased from 65% to 68%.

    The company has provided guidance for FY21 of earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) of US$54 million to US$58 million.

    At the current Pushpay share price, it’s valued at 27x FY23’s estimated earnings according to Commsec. Pushpay is a business that’s liked by fund manager Eley Griffiths Group.

    EML Payments Ltd (ASX: EML)

    According to the ASX, EML Payments has a market capitalisation of $1.4 billion.

    EML Payments is an ASX payment share that offers a wide variety of payment services. It has general purpose reloadable offerings such as gaming payouts with white label gaming cards, salary packaging cards, commission payouts and rewards programs. EML Payments also offers physical gift cards, shopping centre gift cards and digital gift cards. Finally, it offers virtual account numbers.

    The company is seeing a recovery as the world heads back towards somewhat normality from COVID-19.

    For the first FY21 quarter, for the three months to 30 September 2020, first quarter revenue grew 75% to $40.6 million compared to the prior corresponding period and that was 20% higher than the fourth quarter of FY20.

    EML also said it generated $10 million of earnings before interest, tax, depreciation and amortisation (EBITDA) in the first quarter, which was up 215% compared to the prior corresponding period and up 69% compared to the FY20 fourth quarter.

    Sezzle Inc (ASX: SZL)

    According to the ASX, Sezzle has a market capitalisation of $1.1 billion.

    Sezzle is a buy now, pay later (BNPL) business that’s headquartered in the US. Whilst Sezzle is smaller than other competitors like Afterpay Ltd (ASX: APT) and Zip Co Ltd (ASX: Z1P), it is growing at a faster pace in percentage terms.

    The important Black Friday and Cyber Monday sales just happened, which is why Sezzle gave an update for November 2020. The recent Black Friday and Cyber Monday saw UMS of US$28.5 million, which was a 146.4% increase for the ASX payment share

    Sezzle said that its underlying merchant sales (UMS) grew by 188.5% to US$113 million for the whole month. Its annualised UMS stood at US$1.36 billion. Its active merchants were up 164.5% to 24,846 and active consumers grew by 151.5% to 2.07 million.

    Sezzle executive Chair Charlie Youakim said at the time of the update: “We are extremely excited about the direction of our business, as we recently partnered with GameStop and eCommerce platform Wix. Sezzle is now offered at Gamestop’s network of more than 3,300 US retail stores, its online store and in the GameStop mobile app. Our integration on Wix is available to all Wix merchants in the US, Canada, India and in the future will be able in other regions as Sezzle expands internationally.”

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends EML Payments. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Sezzle Inc. The Motley Fool Australia has recommended EML Payments, PUSHPAY FPO NZX, and Sezzle Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 3 compelling ASX payment shares to buy appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3qIKFWk

  • How to protect your super fund when you’re approaching retirement

    Piggy bank wrapped in bubble wrap

    When it comes to superannuation, many people don’t think of it as a conventional ‘portfolio’ so to speak. Rather than simply a basket of ASX shares, a super fund is your retirement fund, a ‘golden ticket to your golden years’ of a comfortable, stress-free, work-free life.

    As such, many people approaching retirement, even those with ASX share portfolios, aren’t comfortable with the level of volatility the share market inevitably brings to investments, whether that be in or out of super. That’s despite shares offering the highest potential growth of any asset class (if historical performance is to be believed), even if that comes with high volatility.

    Thus, most ‘balanced’ superannuation portfolios acknowledge these sentiments by investing in a range of asset classes, not just shares. These usually include fixed-interest assets (bonds), property and cash. This exchanges lower volatility for lower returns, theoretically speaking at least.

    But for those people with retirement just around the corner, a ‘balanced’ approach might not fit the risk profile these investors want to enjoy.

    Luckily, reporting in the Australian Financial Review (AFR) this week provides some tips on protecting your super fund without sacrificing returns unnecessarily.

    Protecting a super portfolio

    One strategy those approaching retirement can use to help shore up their super funds is to employ the use of annuities. Annuities are similar to a pension, in that they provide a guaranteed stream of income in exchange for a lump sum investment. This income might not offer the same kind of bang for your buck as a well-picked portfolio of ASX dividend shares, but it also comes with that invaluable ‘guaranteed stream’ that no dividend share can offer. Many ASX companies offer products like these, including AMP Ltd (ASX: AMP) and Challenger Ltd (ASX: CGF).

    The AFR tells us that an investor approaching retirement could also consider investing in corporate bonds. Corporate bonds are not as ‘safe’ as government bonds as, unlike a government, a company can go broke. However, government bonds offer next to no real return (a 3-year Australian government bond offers a current yield of 0.12% per annum at the time of writing). In contrast though, the AFR says some corporate bonds, such as those from Lendlease Group (ASX: LLC), offer far higher yields, in one case 2.3% per annum.

    Finally, the AFR says that keeping a chunk of funds in cash or cash-like investments can help mitigate volatility. Having a ‘cushion’ like this enables an investor to ride out a market crash until the markets recover without having to sell down shares at the worst possible time.

    Foolish takeaway

    Like most things, there is no right answer for constructing the perfect super portfolio to fit your needs. But with adequate forethought and planning, the chances of successful, happy and comfortable retirement are far higher.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post How to protect your super fund when you’re approaching retirement appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/39ZXENc

  • 2 exciting small cap ASX shares to watch closely in 2021

    Woman in pink sweater lying on dock with binoculars to her eyes

    Are you looking to add a little exposure to the small cap side of the market to your portfolio? If you are, then you might want to take a look at the shares listed below.

    Here’s why these shares have been tipped for big things in the future:

    Mach7 Technologies Ltd (ASX: M7T)

    Mach7 is a growing developer of enterprise imaging and informatics solutions for image viewing, storage, and workflow management. Its solutions can be implemented individually or as a comprehensive end-to-end image management and diagnostic viewing platform.

    Demand has been strong for its offering, leading to some major contract wins this year. One was a seven-year deal with Trinity Health for the license and associated support services for its eUnity enterprise viewer. Trinity Health is the fifth largest healthcare Integrated Delivery Network (IDN) in the United States and will be installing it across multiple facilities within its 92 hospitals.

    Pleasingly, this could be the first of many new contracts. Management revealed that its pipeline is very strong in respect to late-stage deals, which it feels is alluding to a strong second half of FY 2021.

    Analysts at Morgans are positive on the company’s prospects. Earlier this month the broker put an add rating and $1.49 price target on its shares. This compares to the current Mach7 share price of $1.19.

    MyDeal.com.au Limited (ASX: MYD)

    MyDeal.com.au is an online retail marketplace that has a focus on furniture, homewares, appliances, technology, baby products, and hardware. It has been a very strong performer this year. During the first quarter of FY 2021, the company delivered gross sales growth of 317% to $56.67 million. This was driven by the accelerating shift to online shopping and a 268% increase in active customers to 669,897 compared to the prior corresponding period.

    Pleasingly, this strong form has continued since then. MyDeal recently released an update on its performance during Black Friday and Cyber Monday. It performed strongly during the promotional period, leading to a record month of trade in November. MyDeal recorded gross sales of $30 million, up 192% year on year and 63% month on month. Its active customers grew to a record 778,867, up 236% year on year.

    Morgans is also positive on its prospects. Its analysts recently put an add rating and $1.70 price target on its shares. This compares favourably to the current MyDeal share price of $1.21.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 exciting small cap ASX shares to watch closely in 2021 appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3m5NZqK

  • Ask a fund manager: Nikko AM’s Darren Langer and Chris Rands share their insights on fixed income investing

    Nikko Asset Management fund managers Darren Langer and Chris Rands

    In today’s fund manager interview we turn our attention away from the share market and towards an equally important part of most successful investment portfolios.

    Namely, fixed income investments.

    To gain a top insider’s perspective into this market, the Motley Fool reached out to Darren Langer and Chris Rands. Darren is the head of Australian Fixed Income at Nikko Asset Management and both he and Chris are co-portfolio managers of the Nikko AM Australian Bond Fund.

    Nikko AM has 20 years’ experience managing fixed income assets. Rather than passively track an index, the team engages in actively managed, high conviction investing.

    Nikko AM’s Australian Bond Fund only invests in investment grade securities (a BBB- rating or above), and generally holds between 70 and 130 securities. The fund requires a minimum $10,000 initial investment and pays quarterly distributions.

    Launched in July 2000, the fund has delivered a per annum return, net of fees, of 5.6% over 10 years, 7.3% over 2 years and 4.3% over the past year (as at 31 October and assuming the reinvestment of distributions).

    With that background covered, read on for the Motley Fool’s exclusive interview with Darren Langer and Chris Rands.

     

    Let’s start things off with a ‘bond investing 101 question’. Why invest in fixed income as part of your wider portfolio?

    Darren: I’ll start off with one thing and that’s obviously not all fixed income is the same. So do your research on what you’re actually looking for.

    We’re more at the conservative end of the spectrum. Our role in a portfolio is generally a defensive one against risk assets. We’re really in the game of delivering consistent income for investors.

    Fixed income provides a buffer against equity volatility and also provides consistent income over time. Bonds generally give you a positive outcome in most conditions. There are certain times when you book a slight negative, but you’re never really likely to get big drawdowns.

    So it provides a nice steady income and a conservative place to park money if things are very volatile or just to diversify your portfolio.

    What sets Nikko AM’s Australian Bond Fund apart from your competitors?

    Darren: There are a couple of things that we do a little differently. One is that we try very hard not to add volatility to a portfolio. So we tend to invest fairly conservatively. We’re not trying to take really big macro bets. We’re really analysing how things currently look in the market and trying to put bonds in our portfolio that deliver a better performance than the index.

    We’re aiming for about 70 [basis points] over the index, which is the Bloomberg [AusBond] Composite Index. And we try to get that year in and year out, to consistently add value over time and for a reasonable fee.

    Volatility is really the main difference between us and our competitors. Some will take a lot more credit risk in their portfolio, or they’ll take a lot more interest rate risk. So their returns are much more volatile.

    Chris: We try to introduce a lot of little bets rather than one big bet. It reduces the volatility and if you win more often than not, the small bets add up to that consistency through time.

    Darren: The other thing that’s different from some of our competitors is that we spend a lot of time on technology. We’ve found that most people do the same thing in fixed income. The bond market is the bond market. So they’re all doing the same kinds of investments.

    We use technology to try to capture opportunities more regularly and more consistently. We spent a lot of time building a toolkit that we can use to identify and filter lots of different opportunities and to invest in the best ones. We’re ploughing through thousands of ideas every day. We can go through large amounts of data very quickly and then distil what opportunities are there.

    What type of mix of bonds does the fund invest in?

    Darren: We’re a composite fund so we use a combination of all the investment grade universe. That covers government markets, the state governments, offshore sovereigns and it covers the corporate credit market and banking.

    Our process is to rotate into the sector opportunities that have the best relative value and we’ll use different maturities in our portfolio and try to find the best ideas all along the yield curve. And that’s what we’re really talking about when we talk about relative value. We can’t control the level of interest rates but we can buy the best set of assets in each part of the market. And that’s what we think gives us the edge over what some of the funds do.

    Chris: We use mortgage-backed securities and asset-backed securities as well, which tend to provide a slightly higher return for a similar risk as bank bonds.

    Do you predominantly operate in the primary or secondary bond markets?

    Darren: We’re active in both.

    Companies come to the market all the time. Because bonds have a fixed maturity, at the end of which they pay you back money, we then have to invest in something else. New bonds are always coming onto the market, so there’s quite a big primary market. But we’re active in the secondary market as well.

    Generally, we have a 3 to 6-month time horizon when we set something in the portfolio. But that doesn’t mean we sell bonds every 3 to 6 months. That’s when we review our ideas. The average duration of our portfolio is around 5 to 6 years.

    Chris: Government bonds are a huge, very liquid market, so you can shift in and out of those at very low cost. Corporate bonds are less liquid and might only issue $200 million and you might never see the bond again once it’s issued. When you buy corporates, you have to have the mentality that this could be in your portfolio for the full period.

    Typically, in our portfolios, the government sector will turn over a lot more than the corporates. While we don’t always hold them to maturity, we would be buying corporates with the expectation that the credit quality is good enough that we can hold them to maturity.

    So the yields that you’re getting are a combination of the coupon payments and some capital gains from selling them as well?

    Darren: Yes, there is a combination of both. Over the long run, the income on a fixed income portfolio is the main driver of return, but there are opportunities to add value through moving bonds around and trading and picking up capital gains. But it’s really more about income over the long run.

    What factors would determine whether you decide to exit a bond position before maturity?

    Chris: We’re really what you would call relative value managers. If we’re going to sell something, it’s because it’s outperformed relative to its peers. A lot of our process is designed in ticking off the things that have deviated from their peers. The reason that works in fixed income is because it’s a very correlated market.

    For example, a 2026 and 2027 bond should have a pretty similar yield, but at certain points in time, those things can deviate. Our process is designed around picking up those deviations. And once those deviations close, that’s when we look to move out of those positions and get into something else.

    Darren: The main reason you have that grouping is because interest rates are a commonality across all bonds. Where with equities, different companies have different drivers. So equities will move a lot more independently. But with fixed income, interest rates all move together. You do have some idiosyncrasies within each bond, but in general the government bond yield is the driver for most bonds. That’s why we’re a much more highly correlated market than equities.

    What types of risk management strategies do you employ?

    Darren: There are two ways of making returns in fixed income, particularly in a low yield environment.

    You can either keep your risk relatively constant, like we’ve always done, and just accept that interest rates are low, and then try to add as much active return as you possibly can.

    The other alternative is you dial the risk up to get higher returns. We try not to do that. We try to do the same things day in and day out. We just have to accept that at the moment, yields are very low, and try to add something to that. For us, it’s about only taking enough risk to get our returns and delivering what we say we’ll deliver.

    We don’t see any dramatic change in interest rates for some time. But we expect the returns from other asset classes are likely to come down a bit.

    Chris: From the portfolio perspective, there’s limits around how far we can go away from the benchmark on interest rate exposure and credit. We don’t invest below BBB-, which is the lowest rating in investment grade.

    Darren: The other thing we do is not take too much concentration risk. A lot of fixed income funds that have higher returns are generally very concentrated in credit markets. We use credit in our portfolio, but we don’t overuse it. Credit tends to be very correlated to equities, because generally the same sorts of risks drive credit markets as equities. We don’t want to become the same as an equity portfolio, because we’re supposed to be a diversifier.

    Speaking of low rates, what are your thoughts on negative rates, like the German 5-year Bund which is yielding minus 0.72%?

    Darren: Negative cash and negative bond rates require a slightly different answer. We don’t think we’re going to get negative cash rates here because the RBA is very anti-negative cash rates. That doesn’t mean bond rates here couldn’t go negative, but it’s not likely.

    However, we are at the bottom of a rate cycle. Rates can’t go much lower without going negative. So if we hit another rough patch where they need to stimulate the economy, negative rates are still possible.

    Fixed interest funds can handle that. As we’ve seen in Europe, where they’ve had negative rates for some time, the banking system and bond markets are still functional. It’s just not going to be a great income-producing situation. But the style of investing that we do, by switching between the best value assets, we can still eke out a return in that environment.

    Chris: Part of what the ECB has said about negative rates is that it hasn’t actually hurt the banking system as much as people make out. That’s mainly because it also improves credit quality by pushing borrowing costs lower.

    Are there any investments that really stand out as top performers and any you wish you’d avoided?

    Darren: Most of our ideas are around themes rather than individual bonds. Unlike in equities, we are not trying to pick specific companies that will do well but we concentrate on broad sectors and areas of the yield curve that look attractive and then target the bonds in those areas.

    Recently we have had a strong view that state governments have been relatively cheap compared to credit markets and also the federal government. For the last year or so, we’ve been heavily invested in various state government bonds. With the RBA doing quantitative easing and changing some banking rules around state bonds as part of their liquidity, that’s done very well.

    In terms of the other side, we underestimated a bit going into COVID-19 just how aggressively markets would move. We probably underestimated how powerful the whole quantitative easing thing offshore was for credit markets. We probably didn’t have as much exposure to credit as some of our competitors, so that was a bit of a detractor for us. For us, the sector allocation is more important than individual bonds or companies.

    Chris: For us, the past 5 months has been one of our strongest performing periods, so it’s hard to say that anything was ‘a dog’. But when I think back to the start of this year, the area that annoyed me was that we had some inflation bonds in the fund. They protect you against rising inflation and when we came into COVID, and the oil price tanked, that was negative for performance because inflation got killed. So that was probably the most frustrating single position.

    Nikko AM has been certified as carbon neutral (after entering into a carbon offset program with the UK-based international organisation Carbon Footprint Ltd). Has your carbon neutral certification impacted your investing metrics?

    Darren: For us, in fixed income, we’re not an ESG [environmental, social, and governance] fund. We don’t try to be pure ESG, but we use that as part of our credit process and part of our filtering process and it’s an important part of our process.

    Chris: We revamped our ESG process over the past 12 months. We now focus on a negative screen, so we’re removing any kind of ESG companies that we think don’t fit the criteria that meet our investment standards. The idea there is that we’re trying to take out the risk that you get poor practices from a corporate that can destroy the value of that company. For a company to make it into our fund, they need to be solid in E, S, and G… all of those practices.

    Now it’s generally big corporates we’re looking at. And most of them do those things anyway. But a few things do get screened out. A lot of the auto manufacturers have poor governance and issues like that. It won’t necessarily be that the carbon footprint is too large. It will be that our assessment is that this company is not quite up to scratch. But in Australia that’s quite rare. The miners don’t issue many bonds.

    Darren: We don’t own anything. We’re just a lender. We can’t function like activist investors. What we can do is avoid lending to companies that we don’t think do the right thing. That’s why we use that negative screen. It’s about ultimately getting repaid and we want to avoid lending to companies that might not repay us because of various environmental or social conditions.

    The inverse relation between bonds and shares have historically helped to offset portfolio volatility; some are saying this relationship is breaking down. Do you agree?

    Darren: Normally it’s been the case that when equities have a bad run they’re able to cut interest rates, and fixed income markets then perform well. Now that we’re close to zero, it’s much harder to do.

    Our feeling is that fixed income does still provide a defensive roll. It may not give you an offsetting return, and I don’t believe it’s ever really given a perfect offset. Equities can sell off 20-30%. Bonds rarely ever have that kind of return, unless you’re taking significant risk.

    If you want to park your money somewhere to avoid volatility, we think fixed income still provides that. But if you’re looking for something that might give you a perfect offset, that’s going to be less likely with interest rates already very low. Some investors may have heard about risk parity as a way of protecting portfolios but this is actually increasing risk on the fixed income side with leverage, and may introduce other risks.

    Chris: Part of the scare people get is that interest rates go up and that rising rates cause economic stress and then the market falls. And then you could have both bonds and equities doing poorly at the same time. I caution against reading too much into that. If interest rates rise relatively quickly, we’ll see the central banks move in to stop it so that higher rates don’t kill the economy.

    What’s the biggest opportunity and threat for fixed income investors in the year ahead?

    Darren: Starting with the threat, the main thing that hurts fixed income is rising interest rates. We don’t see a huge probability of this. But large interest rate hikes are the biggest risk. Though generally if you do have a hike, the next couple of years deliver pretty good returns for fixed income, so it tends to correct itself.

    The other thing that could hurt fixed income, depending on the style, is some sort of economic downturn that hurts credit markets. For funds that have a lot of credit, it’s a similar sort of outcome that you’d get with equities.

    There’s no real massive upside in fixed income. Generally, you get paid your money back plus some income. Rates falling can help generate capital gains, but we don’t see much opportunity for that with where rates are at the moment. Stable income and capital preservation are probably the main opportunities for the next couple of years.

    Chris: Fixed income is meant to be a defensive asset. People are still concerned about how we’ll make it through this crisis. Some protection makes sense. Long government bonds still give you some of that protection. If things go wrong, they will probably perform quite well. And if things go well, then your equity portfolio is probably doing quite well. Diversification matters.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Ask a fund manager: Nikko AM’s Darren Langer and Chris Rands share their insights on fixed income investing appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/39YqIom

  • 2 ASX growth shares to buy for big returns in 2021

    A man drawing an arrow on a growth chart, indicating a surging share price

    If you’re a growth investor then you’re in luck. This is because the Australian share market is home to a large number of quality shares that have the potential to grow very strongly in the coming years.

    Two top growth shares that have been tipped as buys are listed below. Here’s why they are highly rated:

    a2 Milk Company Ltd (ASX: A2M)

    This infant formula and fresh milk company’s shares have been out of form this year. This share price weakness has been driven largely by concerns that its near term performance could be impacted by the pulling forward of sales into FY 2020 during the pandemic and weakness in the daigou channel. While this certainly appears to be the case, management remains confident that this is just a short term headwind.

    One broker that agrees is Morgans. It believes its challenges are transitory and its share price weakness is a buying opportunity. The broker has an add rating and $17.28 price target on a2 Milk shares. Based on the latest a2 Milk share price, this would mean a potential return of 31% over the next 12 months.

    Nearmap Ltd (ASX: NEA)

    Nearmap is an aerial imagery technology and location data company. Thanks to geographic expansions, new growth initiatives, and the quality of its offering, particularly its new AI product, management believes the company is well-positioned for growth in the future. So much so, it is targeting annualised contract value (ACV) growth of 20% to 40% per annum over the long term, with underlying churn of less than 10%.

    Morgan Stanley appears happy with these targets and is recommending Nearmap as a buy. Last month the broker retained its overweight rating and $3.10 price target on its shares. Based on the current Nearmap share price, this implies potential upside of over 41% over the next 12 months.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nearmap Ltd. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool Australia has recommended Nearmap Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 ASX growth shares to buy for big returns in 2021 appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37OpVn9

  • Goldman Sachs names Healius (ASX:HLS) as a value share to buy

    asx brokers

    The Healius Ltd (ASX: HLS) share price was a particularly positive performer on Wednesday.

    The healthcare company’s shares jumped 7.5% to $3.90 following the release of a positive trading update.

    What was in the Healius update?

    As you might have guessed from the Healius share price reaction, the company has been performing very positively so far in FY 2021.

    Healius advised that its Pathology business continued its strong revenue growth in October and November thanks to a combination of COVID-19 testing and non-COVID revenue growth.

    The Imaging and Day Hospitals businesses were also performing positively, with growth being delivered across all states.

    This strong form and the recent completion of its medical centres sale to BGH Capital, led to the company announcing a $200 million share buyback. This represents almost 10% of its shares outstanding.

    Can the Healius share price go higher?

    Although the Healius share price hit a two-year high on Wednesday, one leading broker believes it can still go higher.

    According to a note out of Goldman Sachs, its analysts believe Healius’ shares are great value and expect consensus earnings upgrades to drive its shares higher in the future.

    The broker has a buy rating and $4.40 price target on its shares. This implies potential upside of almost 13% over the next 12 months excluding dividends.

    It commented: “Prior to today, we were forecasting earnings +20-25% above consensus and, whilst we make only modest revisions to operating profits today, we post +7-22% EPS upgrades to reflect the new share buy-back program.”

    “Trading at 10.2x pre-AASB EBITDA (or 6.0x post-AASB) for +8% EBITDA CAGR (FY21-24E), HLS is one of the few value-oriented stocks in the ASX healthcare sector, and we believe it should be considered a core holding ahead of CY21. We expect consensus upgrades and multiple re-rating to drive further stock performance through the mid-term,” it concluded.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Goldman Sachs names Healius (ASX:HLS) as a value share to buy appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2VYFBPu

  • 2 ASX dividend shares with attractive yields to buy

    blockletters spelling dividends

    If you’re wanting to beat the ultra-low interest rates on offer with term deposits, then you might want to look to the share market.

    Two ASX dividend shares that offer investors attractive yields right now are listed below. Here’s what you need to know about them:

    Bravura Solutions Ltd (ASX: BVS)

    Bravura is a leading wealth management and transfer agency software solution provider. Its key product is the Sonata wealth management platform, which streamlines the administration of a full range of wealth management products. It also allows users to connect with their clients through the web and mobile devices. In addition to this, Bravura has a number of other solutions with large addressable markets. This includes the Rufus transfer agency solution, the Garradin back office solution, and the Midwinter financial planning solution.

    Goldman Sachs is positive on the company and has a buy rating and $4.50 price target on its shares. The broker is also forecasting a 10.6 cents per share dividend in FY 2021. Based on the current Bravura share price, this represents a 3.2% dividend yield.

    Wesfarmers Ltd (ASX: WES)

    Wesfarmers is a leading conglomerate that owns a wide range of popular businesses including Kmart, Target, Catch, Officeworks, and Bunnings. The latter is the company’s biggest contributor to its overall earnings. Which has been a big positive this year, as the hardware giant has been in fine form. Pleasingly, it has continued this positive trend in FY 2021 and delivered sales growth of 25.2% for the first four months of the financial year.

    According to a note out of Morgan Stanley from last month, its analysts have pencilled in a 160 cents per share fully franked dividend in FY 2021. Based on the current Wesfarmers share price, this represents an attractive forward 3.2% dividend yield.

    These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

    Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

    Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

    Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

    Returns As of 6th October 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 ASX dividend shares with attractive yields to buy appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3oGP36n

  • 5 things to watch on the ASX 200 on Thursday

    Young man looking afraid representing ASX shares investor scared of market crash

    On Wednesday the S&P/ASX 200 Index (ASX: XJO) was on form again and continued its positive run. The benchmark index climbed 0.6% to 6,728.5 points.

    Will the market be able to build on this on Thursday? Here are five things to watch:

    ASX 200 expected to drop.

    The Australian share market looks to have run out of steam and is expected to drop lower on Thursday. According to the latest SPI futures, the ASX 200 is poised to open the day 49 points or 0.7% lower this morning. This follows a disappointing night on Wall Street, which in late trade sees the Dow Jones down 0.6%, the S&P 500 down 1%, and the Nasdaq down a sizeable 2.1%.

    Tech shares on watch.

    Australian tech shares such as Afterpay Ltd (ASX: APT) and WiseTech Global Ltd (ASX: WTC) could come under pressure on Thursday after their U.S. counterparts sank lower. On Wall Street the Nasdaq is down 2.1% in late trade. As the local tech sector has a tendency to follow its lead, this could mean a tough day lies ahead. Investors appear to be taking profit after the Nasdaq recently hit a record high.

    Oil prices mixed.

    Energy producers including Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) will be on watch today after another mixed night for oil prices. According to Bloomberg, the WTI crude oil price is down 0.1% to US$45.55 a barrel and the Brent crude oil price is flat at US$48.87 a barrel. A surprise inventory build is weighing on prices.

    Gold price sinks.

    It could be a tough day for gold miners such as Newcrest Mining Ltd (ASX: NCM) and Saracen Mineral Holdings Limited (ASX: SAR) after the gold price sank lower. According to CNBC, the spot gold price is down 2.2% to US$1,833.0 an ounce. Vaccine optimism has given risk sentiment a boost and is weighing on safe haven assets.

    Healius rated as a buy.

    The Healius Ltd (ASX: HLS) share price jumped 7% higher yesterday after a trading update but could still go higher. That’s the view of Goldman Sachs, which has slapped a buy rating and $4.40 price target on the healthcare company’s shares. It commented: “HLS is one of the few value-oriented stocks in the ASX healthcare sector, and we believe it should be considered a core holding ahead of CY21. We expect consensus upgrades and multiple re-rating to drive further stock performance through the mid-term.”

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO and WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3m8Olx6

  • 2 fantastic ASX healthcare shares to buy for 2021

    Doctor with stethoscope in hand and data graph showing upward trend

    Due to ageing populations, better technologies and treatments, and increasing chronic disease burden, demand for healthcare services is expected to continue to increase over the next few decades.

    This bodes well for healthcare shares and has many tipping them to continue to outperform over the long term.

    Two healthcare shares that are highly rated are listed below:

    CSL Limited (ASX: CSL)

    CSL is one of the world’s leading biotherapeutics companies. It is made up of the high quality CSL Behring and Seqirus businesses. CSL Behring is the global leader in plasma therapies and Seqirus is the second largest influenza vaccines business.

    Both businesses have been growing at a solid rate in recent years and have been tipped to continue doing so in the future. This is due to their leading therapies and lucrative research and development pipelines.

    CSL’s pipeline contains a number of highly promising products that have the potential to generate significant revenues in the future. This includes clazakizumab, which is being developed to treat kidney transplant rejection. This product alone could generate peak sales of US$5.4 billion eventually.

    UBS recently retained its buy rating and $346.00 price target on CSL’s shares. This compares to the latest CSL share price of $304.14.

    ResMed Inc. (ASX: RMD)

    ResMed has been growing at a such a strong rate over the last decade it has now become one of the world’s leading sleep treatment companies. Pleasingly, it has started the new decade just as strongly as it finished the last. In FY 2020, it delivered a 15% increase in revenue to US$2,957 million and a 32% jump in net income to US$692.8 million.

    The good news is that it has started FY 2021 strongly and appears well-placed to continue this positive form in the future. This is thanks to its world-class products and the massive number of undiagnosed sleep apnoea sufferers globally.

    The company also has a rapidly growth digital health ecosystem, which reached over 12 million cloud connectable medical devices in 2020. This provides ResMed with strong recurring revenues and a material amount of high quality data.

    Last month Credit Suisse put an outperform rating and $31.00 price target on ResMed’s shares. This compares to the current ResMed share price of $28.58.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 fantastic ASX healthcare shares to buy for 2021 appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2Loi0pn

  • ASX 200 up again on Wednesday

    ASX 200

    The S&P/ASX 200 Index (ASX: XJO) went up 0.6% to 6,729 points today.

    Here are some of the highlights from the ASX today:

    Commonwealth Bank of Australia (ASX: CBA)

    CBA announced an update about its divestments today.

    The China Banking and Insurance Regulatory Commission (CBIRC) has granted approval for the divestment of CBA’s 37.5% equity interest in BoCommLife to MS&AD Insurance Group Holdings.

    The final sales proceeds expected to be received by CBA are $886 million. The divestment of the equity interest in BoCommLife is expected to be completed by 31 December 2020.

    CBA also said that it has revised the calculation of non-cash gains and losses on the disposal of previously announced divestments including BoCommLife, CFS, CFSGAM, CommInsure Life and Ausiex. The revisions include the finalisation of accounting adjustments for goodwill, foreign currency translation reverse recycling and updated estimates for transaction and separation costs.

    The total increase in unaudited post-tax statutory earnings related to the completion of BoCommLife and other divestments is expected to be approximately $840 million, which will be recognised as a non-cash item in the FY21 first half result.

    The capital impact of the divestments is a pro-forma uplift to the common equity tier 1 (CET1) ratio of 29 basis points.

    Infratil Ltd (ASX: IFT)

    The New Zealand infrastructure business announced today that it had knocked back the latest takeover offer from AustralianSuper to buy the whole Infratil business.

    Infratil said that the latest offer implied a total value offer of NZ$7.43 per Infratil share, which represented a 22.2% premium to the 8 December 2020 closing share price for Infratil.

    The company said that its board reviewed the valuation and the proposed structure and unanimously rejected AustralianSuper’s offer because it materially undervalued Infratil’s high quality and unique portfolio of assets on a control basis.

    The Infratil board said it would consider any proposal to maximise shareholder value, but given the significant deficiencies in the proposal, no further engagement is planned right now.

    Infratil’s Chair Mark Tume said: “The board regularly assesses portfolio construction and return expectations. We have had a long and successful track record as active managers of the Infratil platform, and recent examples include the ongoing success of CDC Data Centres, the proposed acquisition of Qscan and the strategic review of Tilt Renewables. As at 8 December 2020, Infratil had delivered total shareholder returns of 18% per annum since listing in 1994 and has a stated annual targeted for our shareholders of 11% to 15% over the long term.”

    The Infratil share price went up 1.5%. 

    Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) AGM

    Soul Patts held its annual general meeting (AGM) meeting today. The Soul Patts share price finished the day higher by 2.4%.

    One of the main takeaways was relating to its resources assets. Thermal coal prices are up 33% in the first four months of FY21. This affects its New Hope Corporation Limited (ASX: NHC) shares as one of the biggest coal miners in Australia. Soul Patts decided to sell down its holding of New Hope from 50% to 44%.

    Copper and zinc prices have also gone up in the first four months of FY21, rising by 20% and 21% respectively. This relates to Soul Patts’ private Round Oak business.

    Soul Patts also said that that first quarter building products performance from Brickworks Limited (ASX: BKW) was well above the same period last year.

    The financial services portfolio has risen 16% and the pharmaceutical portfolio has gone up 10% in the first four months of FY21.

    In terms of an outlook, Soul Patts said that cash generation from the portfolio remains strong to support dividends. It also said that liquidity is available for new investments, where Soul Patts is looking across a range of industries.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Tristan Harrison owns shares of Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia owns shares of and has recommended Brickworks and Washington H. Soul Pattinson and Company Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX 200 up again on Wednesday appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37Hk0jS